Tectonic Therapeutic, Inc. (TECX) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Tectonic Therapeutic, Inc. on April 23, 2026. The filing reports the appointment of a new director and member of the Audit Committee, effective as of the Company's 2026 annual stockholder meeting.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and director compensation arrangements.
Material Changes
The primary material change reported is the appointment of Jessica Chutter to the Board of Directors and the Audit Committee. There are no reported changes to financial performance or operational status in this document.
Management Commentary and Compensation Details
The Board determined that Ms. Chutter qualifies as an independent director. Her compensation package under the non-employee director policy includes:
- Cash Retainer: $40,000 annually for Board service.
- Committee Fee: Additional $7,500 annually for Audit Committee service.
- Initial Equity Award: Options to purchase 20,400 shares of common stock under the 2024 Equity Incentive Plan.
- Vesting Schedule: One-third of the initial award vests on the first anniversary of the grant date; the remainder vests in equal monthly installments over the subsequent two years, subject to continued service.
- Change in Control: All outstanding equity awards vest immediately prior to a change in control if Ms. Chutter remains in continuous service.
Ms. Chutter will serve as a Class III director with a term expiring at the 2027 annual stockholder meeting. An indemnification agreement was also executed.
Investor Verification Checklist
- Verify the exact date of the 2026 Annual Stockholder Meeting to confirm the effective date of Ms. Chutter's appointment.
- Review the 2024 Equity Incentive Plan to understand the specific terms of the stock options granted.
- Confirm the total number of authorized shares under the 2024 Plan to assess the impact of the 20,400 share grant.
- Check for any subsequent filings regarding the outcome of the 2026 Annual Meeting.